James S, Erlinge D, Storey RF, McGuire DK, et al. Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction. Am Heart J 2023 Aug 25:S0002-8703(23)00207-7. doi: 10.1016/j.ahj.2023.
PMID: 37648579